Adenosine deaminase deficiency: a review.
Flinn AM, Gennery AR.
Orphanet J Rare Dis. 2018 Apr 24;13(1):65. doi: 10.1186/s13023-018-0807-5.
Deficiency of Adenosine Deaminase 2.
Coşkun Ç, Ünal Ş.
Turk J Haematol. 2024 Aug 28;41(3):133-140. doi: 10.4274/tjh.galenos.2024.2024.0265. Epub 2024 Aug 9.
Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID).
Secord E, Hartog NL.
Ther Clin Risk Manag. 2022 Sep 22;18:939-944. doi: 10.2147/TCRM.S350762. eCollection 2022.
Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity.
Signa S, Bertoni A, Penco F, Caorsi R, Cafaro A, Cangemi G, Volpi S, Gattorno M, Schena F.
Front Immunol. 2022 Jul 11;13:935957. doi: 10.3389/fimmu.2022.935957. eCollection 2022.
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.
Kohn DB, Booth C, Shaw KL, Xu-Bayford J, Garabedian E, Trevisan V, Carbonaro-Sarracino DA, Soni K, Terrazas D, Snell K, Ikeda A, Leon-Rico D, Moore TB, Buckland KF, Shah AJ, Gilmour KC, De Oliveira S, Rivat C, Crooks GM, Izotova N, Tse J, Adams S, Shupien S, Ricketts H, Davila A, Uzowuru C, Icreverzi A, Barman P, Campo Fernandez B, Hollis RP, Coronel M, Yu A, Chun KM, Casas CE, Zhang R, Arduini S, Lynn F, Kudari M, Spezzi A, Zahn M, Heimke R, Labik I, Parrott R, Buckley RH, Reeves L, Cornetta K, Sokolic R, Hershfield M, Schmidt M, Candotti F, Malech HL, Thrasher AJ, Gaspar HB.
N Engl J Med. 2021 May 27;384(21):2002-2013. doi: 10.1056/NEJMoa2027675. Epub 2021 May 11.
Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.
Pilania RK, Banday AZ, Sharma S, Kumrah R, Joshi V, Loganathan S, Dhaliwal M, Jindal AK, Vignesh P, Suri D, Rawat A, Singh S.
Front Immunol. 2022 May 3;13:869570. doi: 10.3389/fimmu.2022.869570. eCollection 2022.
Balancing early detection of adenosine deaminase deficiency with overdiagnosis risk.
Revak S, Shaker M, Sun D.
Ann Allergy Asthma Immunol. 2022 Dec;129(6):665-666. doi: 10.1016/j.anai.2022.09.013.
A Narrative Review of the Neurological Manifestations of Human Adenosine Deaminase 2 Deficiency.
Dzhus M, Ehlers L, Wouters M, Jansen K, Schrijvers R, De Somer L, Vanderschueren S, Baggio M, Moens L, Verhaaren B, Lories R, Bucciol G, Meyts I.
J Clin Immunol. 2023 Nov;43(8):1916-1926. doi: 10.1007/s10875-023-01555-y. Epub 2023 Aug 7.
Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.
Kohn DB, Hershfield MS, Puck JM, Aiuti A, Blincoe A, Gaspar HB, Notarangelo LD, Grunebaum E.
J Allergy Clin Immunol. 2019 Mar;143(3):852-863. doi: 10.1016/j.jaci.2018.08.024. Epub 2018 Sep 5.
Polyarteritis nodosa.
Bilginer Y, Ozen S.
Curr Opin Pediatr. 2022 Apr 1;34(2):229-233. doi: 10.1097/MOP.0000000000001106.
